Pro-Dex (PDEX) vs Utah Medical Products (UTMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pro-Dex (PDEX) has outperformed Utah Medical Products (UTMD) over the past year, gaining 91.3% versus a gain of 16.2%. Over five years, PDEX leads with a +144.3% price change compared with -18.4% for UTMD. Utah Medical Products is the larger company by market cap ($233.1 million vs $203.0 million), about 1.1 times the size.
On valuation, Pro-Dex trades at a lower trailing P/E (15.2x vs 22.4x for Utah Medical Products). Utah Medical Products pays a dividend yielding 1.68%, while Pro-Dex does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PDEX | UTMD |
|---|---|---|
| Share price | $62.80 | $73.45 |
| Market cap | $203.05M | $233.12M |
| 1-day change | -3.27% | -0.51% |
| YTD return | +63.20% | +31.25% |
| 1-year return | +91.35% | +16.18% |
| 5-year return | +144.26% | -18.41% |
| P/E ratio (TTM) | 15.24 | 22.39 |
| Forward P/E | 18.69 | — |
| EPS (TTM) | $4.12 | $3.28 |
| Dividend yield | 0.00% | 1.68% |
| Annual dividend | $0.00 | $1.24 |
| 52-week high | $77.00 | $76.89 |
| 52-week low | $23.47 | $53.66 |
| Distance from 52-week high | -18.44% | -4.47% |
| Analyst consensus | none | — |
| Avg. price target upside | +17.83% | — |
| Average volume | 81.57K | 34.21K |
| Shares outstanding | 3.23M | 3.17M |
| Employees | 201 | 140 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PDEX has outperformed UTMD by 75.2 percentage points over the past year.
- Utah Medical Products trades at a higher earnings multiple (22.4x vs 15.2x trailing P/E).
- Utah Medical Products offers a meaningfully higher dividend yield (1.68% vs 0.00%).
About Pro-Dex
PDEX stock →Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide.
Health Care · Medical/Dental Instruments · 201 employees
About Utah Medical Products
UTMD stock →Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.
Health Care · Medical/Dental Instruments · 140 employees
PDEX vs UTMD FAQ
Which is bigger, Pro-Dex or Utah Medical Products?
Utah Medical Products (UTMD) is larger, with a market capitalization of $233.12M compared with $203.05M for Pro-Dex (PDEX).
Which stock has performed better over the past year, PDEX or UTMD?
PDEX returned +91.35% over the past 12 months, compared with +16.18% for UTMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, PDEX or UTMD?
PDEX has the lower trailing P/E at 15.2, versus 22.4 for UTMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Pro-Dex or Utah Medical Products?
Utah Medical Products pays a dividend yielding 1.68%, while Pro-Dex does not currently pay a regular dividend.
Are Pro-Dex and Utah Medical Products in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.